FDA Approves Brekiya (dihydroergotamine mesylate) Injection ...
All News Consumer Pro New Drugs Pipeline Clinical Trials FDA Alerts FDA Approves Brekiya FDA Approves Brekiya (dihydroergotamine mesylate) Injection for the Acute Treatment of …
Amneal Pharmaceuticals, Inc. - Amneal Receives U.S. FDA ...
May 15, 2025 · Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
Best New Migraine Medications and Treatments — Migraine Again
Jun 6, 2025 · The past several years have seen more advancements in migraine-specific treatments than in the past three decades. Let that sink in. Since 2018, several new therapies …
New Treatments for Migraines: What Actually Works in 2025?
May 26, 2025 · What are the most effective new treatments for migraines in 2025? The most effective new treatments include CGRP-targeted therapies such as oral gepants (rimegepant, …
FDA Approves Brekiya, First and Only DHE Autoinjector, for ...
May 15, 2025 · The FDA approved a dihydroergotamine (DHE) mesylate injection (Brekiya; Amneal Pharmaceuticals), the first and only DHE autoinjector for acute treatment of migraine …